ICU Medical/$ICUI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ICU Medical
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Ticker
$ICUI
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
15,000
ISIN
US44930G1076
Website
ICU Medical Metrics
BasicAdvanced
$3.3B
-
-$3.83
0.88
-
Price and volume
Market cap
$3.3B
Beta
0.88
52-week high
$181.06
52-week low
$117.92
Average daily volume
226K
Financial strength
Current ratio
2.594
Quick ratio
0.87
Long term debt to equity
74.889
Total debt to equity
80.574
Interest coverage (TTM)
1.12%
Profitability
EBITDA (TTM)
334.676
Gross margin (TTM)
35.08%
Net profit margin (TTM)
-3.87%
Operating margin (TTM)
4.98%
Effective tax rate (TTM)
-133.36%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
1.78%
Return on equity (TTM)
-4.62%
Valuation
Price to revenue (TTM)
1.372
Price to book
1.68
Price to tangible book (TTM)
-18.15
Price to free cash flow (TTM)
27.36
Free cash flow yield (TTM)
3.65%
Free cash flow per share (TTM)
496.09%
Growth
Revenue change (TTM)
7.22%
Earnings per share change (TTM)
56.00%
3-year revenue growth (CAGR)
16.23%
10-year revenue growth (CAGR)
22.59%
3-year earnings per share growth (CAGR)
27.14%
10-year earnings per share growth (CAGR)
7.53%
What the Analysts think about ICU Medical
Analyst ratings (Buy, Hold, Sell) for ICU Medical stock.
Bulls say / Bears say
ICU Medical's joint venture with Otsuka Pharmaceutical Factory, completed in May 2025, creates one of the largest global IV solutions manufacturing networks, enhancing supply chain resiliency and innovation in North America. (icumed.com)
The FDA's clearance of ICU Medical's Plum Solo™ and Plum Duo™ precision IV pumps in April 2025 introduces a new category of infusion devices with ±3% accuracy, potentially increasing market share. (icumed.com)
StockNews.com upgraded ICU Medical's rating to 'Buy' in March 2025, reflecting positive investor sentiment and confidence in the company's growth prospects. (americanbankingnews.com)
The FDA issued a warning letter to ICU Medical in April 2025 for failing to submit premarket notifications for changes to infusion pumps, indicating potential regulatory challenges. (medtechdive.com)
ICU Medical announced the permanent closure of its Oakdale, Minnesota facility in July 2024, resulting in 83 layoffs, which may signal operational challenges. (medtechdive.com)
The company has faced multiple recalls and quality issues since acquiring Smiths Medical in 2022, potentially affecting its reputation and financial performance. (medtechdive.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.
ICU Medical Financial Performance
Revenues and expenses
ICU Medical Earnings Performance
Company profitability
ICU Medical News
AllArticlesVideos
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Accesswire·1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Accesswire·2 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ICU Medical stock?
ICU Medical (ICUI) has a market cap of $3.3B as of July 10, 2025.
What is the P/E ratio for ICU Medical stock?
The price to earnings (P/E) ratio for ICU Medical (ICUI) stock is 0 as of July 10, 2025.
Does ICU Medical stock pay dividends?
No, ICU Medical (ICUI) stock does not pay dividends to its shareholders as of July 10, 2025.
When is the next ICU Medical dividend payment date?
ICU Medical (ICUI) stock does not pay dividends to its shareholders.
What is the beta indicator for ICU Medical?
ICU Medical (ICUI) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.